Anthem Biosciences to Hold Board Meeting for Q1 FY2026 Results; Trading Window Closed from July 1

Anthem Biosciences to Hold Board Meeting for Q1 FY2026 Results; Trading Window Closed from July 1

Anthem Biosciences to Hold Board Meeting for Q1 FY2026 Results; Trading Window Closed from July 1​

Anthem Biosciences Limited, formerly known as Anthem Biosciences Pvt. Ltd., has scheduled a Board meeting to approve the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026. The management confirmed that during this period, specific restrictions were placed on trading in the company’s equity shares.

The Board of Directors is set to convene on Tuesday, July 21, 2026, with the primary agenda item being the consideration and approval of the financial results for the quarter ended June 30, 2026.

In addition to the board meeting announcement, the company also confirmed that the trading window for dealing in Equity Shares was closed starting July 01, 2026. This restriction period is scheduled to continue until the close of trading hours on July 23, 2026. This two-week restriction covers the forty eight hours following the declaration of the financial results for the quarter ended June 30, 2026, and relates to internal policies governing trading by employees and other connected persons.

GODIGIT Stock Price Movement​

On Tuesday, Go Digit General Insurance Limited shares gained 0.91% to close at ₹307.8, demonstrating solid upward momentum. The stock traded with a volume of 315,392 shares after hitting a day low of ₹299 and peaking at ₹310.15.
 

Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.

The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.

Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.

Back
Top